Similar articles

• Circulating TNFRI and TNFRII levels correlated with the disease activity score (DAS28) in rheumatoid arthritis.

  Valle Y, Ledezma-Lozano IY, Torres-Carrillo N, Padilla-Gutiérrez JR, Navarro-Hernández RE, Vázquez-Del Mercado M, Palafox-Sánchez CA, Armendáriz-Borunda J, Muñoz-Valle JF. Valle Y, et al. Scand J Rheumatol. 2009;38(5):332-5. doi: 10.1080/03009740902865456. Scand J Rheumatol. 2009. PMID: 19579138
• Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis.

  Glossop JR, Dawes PT, Nixon NB, Mattey DL. Glossop JR, et al. Arthritis Res Ther. 2005;7(6):R1227-34. doi: 10.1186/ar1816. Epub 2005 Sep 7. Arthritis Res Ther. 2005. PMID: 16277675 Free PMC article.
• Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.

  Mahmoud RA, El-Gendi HI, Ahmed HH. Mahmoud RA, et al. Clin Biochem. 2005 Feb;38(2):134-41. doi: 10.1016/j.clinbiochem.2004.11.002. Clin Biochem. 2005. PMID: 15642275
• A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach.

  Tedesco A, D'Agostino D, Soriente I, Amato P, Piccoli R, Sabatini P. Tedesco A, et al. Autoimmun Rev. 2009 Jan;8(3):233-7. doi: 10.1016/j.autrev.2008.07.031. Epub 2008 Aug 15. Autoimmun Rev. 2009. PMID: 18708166 Review.
• [Anti-citrullinated peptide antibodies: novel markers for rheumatoid polyarthritis].

  Yalaoui S. Yalaoui S. Arch Inst Pasteur Tunis. 2006;83(1-4):13-7. Arch Inst Pasteur Tunis. 2006. PMID: 19388592 Review. French.